# US 2018/0022774 A1 · Process for the preparation of sofosbuvir

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0022774 A1
- Document ID: US20180022774A1
- Status: Published application
- Kind: A1
- Application number: 15/589,691
- Filed: 2017-05-08
- Published: 2018-01-25
- Earliest claimed: 2016-07-20
- Assignees: Optimus Drugs (P) Limited
- Applicants: Optimus Drugs (P) Limited
- Inventors: Srinivas Reddy Desi Reddy; Srinivas Rao Velivela
- Web page: https://patentgrep.com/patent/US20180022774A1

## CPC

- C07H 19/10: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 1/02: Phosphorylation
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The present invention relates to an improved, commercially viable and industrially advantageous process for the preparation of sofosbuvir, which uses reagents that are less expensive and easier to handle.

## Claims

### Claim 1

A process for the preparation of sofosbuvir of formula (I) comprising the step of (a) reacting a compound of formula (III) with a compound of formula (II) in the presence of a metallic salt, a base and a solvent to obtain a compound of formula (I)

### Claim 2 (depends on 1)

The process of claim 1, wherein the compound of formula (III) is prepared by:
(i) deprotecting a compound of formula (V) under acidic conditions to obtain a compound of formula (IV)
and
(ii) hydrolyzing the compound of formula (IV) in the presence of a base and a solvent to obtain a compound of formula (III)

### Claim 3 (depends on 2)

A process according to the claim 2, wherein each solvent in steps (a) and (ii) is independently selected from acetone, tetrahydrofuran, acetonitrile, ethyl acetate, dimethylformamide, dichloromethane, methyl tertiary butyl ether, acetic acid, methanol, ethanol, isopropanol, water and mixtures thereof.

### Claim 4 (depends on 3)

A process according to claim 3, wherein each solvent in steps (a) and (ii) is independently selected from methanol, tetrahydrofuran, and mixtures thereof.

### Claim 5 (depends on 2)

A process according to claim 2, wherein the solvent in step (a) is tetrahydrofuran.

### Claim 6 (depends on 2)

A process according to claim 2, wherein the solvent in step (ii) is methanol.

### Claim 7 (depends on 2)

A process according to claim 2, wherein each base in steps (a) and (ii) is independently selected from triethylamine, diisopropylethylamine, diisopropylamine, pyridine, ammonium acetate, ammonium chloride, ammonium formate, ammonium sulfamate, ammonium phosphate, ammonium citrate, ammonium carbamate, ammonia, and mixtures thereof.

### Claim 8 (depends on 7)

A process according to claim 7, wherein each base in steps (a) and (ii) is independently selected from triethyl amine, diisopropylethylamine, ammonia, and mixtures thereof.

### Claim 9 (depends on 2)

A process according to claim 2, wherein the base in step (a) is ammonium chloride.

### Claim 10 (depends on 2)

A process according to claim 2, wherein the base in step (ii) is ammonia.

### Claim 11 (depends on 1)

A process according to claim 1, wherein the metallic salt is selected from magnesium chloride, magnesium bromide, magnesium iodide, lithium chloride, lithium bromide, lithium iodide, copper chloride, copper bromide, copper iodide, and mixtures thereof.

### Claim 12 (depends on 11)

A process according to claim 11, wherein the metallic salt is magnesium chloride.

### Claim 13 (depends on 1)

A process according to claim 1, wherein step (a) is performed in the absence of a Grignard reagent.

### Claim 14 (depends on 2)

A process according to the claim 2, wherein the compound of formula (V) is deprotected by reaction with a deprotection agent selected from trifluoroacetic acid, sulphuric acid, methane sulphonic acid, acetic acid, formic acid, hydrochloric acid, and mixtures thereof.

### Claim 15 (depends on 1)

A process according to claim 1, wherein the compound of formula (I) is recrystallized in the presence of an ether solvent.

### Claim 16 (depends on 15)

A process according to claim 15, wherein the ether solvent is selected from diethyl ether, diisopropyl ether, MTBE (methyl tertiary butyl ether), and mixtures thereof.

### Claim 17 (depends on 16)

A process according to claim 16, wherein the ether solvent is MTBE.

### Claim 18

A composition comprising (a) sofosbuvir and (b) a metallic salt selected from magnesium chloride, magnesium bromide, magnesium iodide, lithium chloride, lithium bromide, lithium iodide, copper chloride, copper bromide, copper iodide, and mixtures thereof, wherein the weight ratio of sofosbuvir to the metallic salt is at least 99.95:0.05.

### Claim 19 (depends on 18)

A composition according to claim 18, wherein the weight ratio of sofosbuvir to the metallic salt is at least 99.98:0.02.
